UBS’s Vericel Corp VCEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$4K Buy
1,373
+1,366
+19,514% +$4.52K ﹤0.01% 9652
2014
Q2
$0 Sell
7
-231
-97% -$957 ﹤0.01% 10852
2014
Q1
$1K Buy
238
+74
+45% +$279 ﹤0.01% 10231
2013
Q4
$1K Buy
164
+151
+1,162% +$590 ﹤0.01% 10210
2013
Q3
$0 Buy
13
+7
+117% +$50 ﹤0.01% 10744
2013
Q2
$0 Buy
+6
New +$72 ﹤0.01% 10195

Other funds holding VCEL

UBS's VCEL Position: Q3 2014 in Review

UBS increased its Vericel Corp (VCEL) stake by 19,514% in Q3 2014, buying an estimated $4.52K and bringing the position to 1,373 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #9652.

UBS first reported a position in VCEL in Q2 2013 and has held it in 6 quarters since. 31 funds tracked by Wall St. Rank hold VCEL as of Q3 2014.

  • UBS held 1,373 shares of Vericel Corp worth $4K as of Q3 2014.
  • UBS bought 1,366 Vericel Corp shares in Q3 2014, an estimated $4.52K.
  • Vericel Corp made up ﹤0.01% of UBS's portfolio in Q3 2014, its #9652 holding.
  • UBS first reported a position in Vericel Corp in Q2 2013 and has held it in 6 quarters since.
  • 31 funds tracked by Wall St. Rank held Vericel Corp as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.